Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Manufacturing
Acuitas takes majority stake in Montreal-based RNA manufacturer
Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based RNA Technologies & Therapeutics.
Joseph Keenan
Jan 8, 2026 9:12am
AstraZeneca extends Niowave radioisotope supply deal by 10 years
Dec 23, 2025 7:47am
Fierce Biotech
Ramaswamy-backed Ambros launches with $125M to develop pain med
Dec 16, 2025 1:32pm
Microsize buys Lonza micronization plant for undisclosed price
Dec 1, 2025 11:45am
Fierce Biotech
Pfizer finalizes Metsera buy after contentious Novo bidding war
Nov 13, 2025 12:43pm
Fierce Biotech
Pfizer beats out Novo with $10B agreement to buy Metsera
Nov 8, 2025 8:11am